Skip to main content
. 2021 Jun 14;142(3):475–494. doi: 10.1007/s00401-021-02325-z

Fig. 5.

Fig. 5

Representative results for five controls and five R1441G mutation carriers. a Immunoblotting of neutrophils isolated from five R1441G LRRK2 mutation carriers with PD (n = 2) and non-manifesting carrier status (n = 3) as well as five controls with duplicate loading of 10 µg of DMSO and MLi-2 (200 nM MLi-2, 30 min) treated whole cell extracts using antibodies against total LRRK2, pSer935 LRRK2, total Rab10, MJFF-pRAB10 (pThr73) and GAPDH. (b) Quantification of immunoblots of two independent experiments by analysing pRab10Thr73 /total Rab10 ratio of DMSO treated samples b per individual and c per group with group difference calculated by unpaired t test (***p = 0.0007). d The respective summed intensities of fragment ion transitions are represented with different colours as shown in the bottom panel of the graph. e Relative endogenous pRab10 peak areas of two independent analysis for pRab10Thr73 occupancy depicted as a bar graph for DMSO and MLi-2 treated samples of all ten participants and f per group with group difference calculated by unpaired t test (**p = 0.0014)